Ten X Genomics Stock Surges, But Long-Term Challenges Persist
Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Wednesdays
Categories:
Ten X Genomics stock surges after Canaccord Genuity raises target price, following better-than-expected earnings. Despite recent gains, long-term investors still face challenges, as shares bought five years ago are now worth less than half their initial value.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
